D-Pharm seeking Thrombotech acquisition after Phase III halt

D-Pharm Ltd. (Tel Aviv:DPRM) said it is in negotiations to acquire stroke company Thrombotech

Read the full 149 word article

How to gain access

Continue reading with a
two-week free trial.